Yourgene Health sees stronger second-half ahead
International molecular diagnostics group Yourgene Health (YGEN:AIM) reported revenues up a mere 5% to £8.2 million for the six-months to 30 September, a period impacted by Covid-19 restrictions. The shares dropped 6.4% to 18.4p on...
26 October 2020